DaVita Inc. (DVA)

57.01
0.29 0.51
NYSE : Health Services
Prev Close 56.72
Open 56.71
Day Low/High 56.39 / 57.61
52 Wk Low/High 43.40 / 79.11
Volume 855.03K
Avg Volume 3.03M
Exchange NYSE
Shares Outstanding 160.30M
Market Cap 8.92B
EPS 0.90
P/E Ratio 16.77
Div & Yield N.A. (N.A)
DaVita's Corporate Responsibility Efforts Earn Accolades From Dow Jones

DaVita's Corporate Responsibility Efforts Earn Accolades From Dow Jones

Company makes Dow Jones Sustainability Indices (DJSI) for the third time

13th Annual Tour DaVita Cycling Event Raises $1.2M For Bridge Of Life

13th Annual Tour DaVita Cycling Event Raises $1.2M For Bridge Of Life

Cyclists collectively rode more than 90,000 miles through Pennsylvania to raise awareness about kidney disease

7 Medical Products Stocks With the Right Prescription for Gains

7 Medical Products Stocks With the Right Prescription for Gains

Top picks in the fast-growing medical products market.

Markets Barely Blinked: Cramer's 'Mad Money' Recap (Monday 9/16/19)

Markets Barely Blinked: Cramer's 'Mad Money' Recap (Monday 9/16/19)

Jim Cramer says it's amazing the market didn't fall on this oil shock. The U.S. is very different than it was a decade ago, he explains.

McDonald's, Ulta Beauty, DaVita: 'Mad Money' Lightning Round

McDonald's, Ulta Beauty, DaVita: 'Mad Money' Lightning Round

Jim Cramer takes a look at McDonald's, Ulta Beauty, DaVita, Coupa Software, Valley National Bancorp, Cliffs Natural Resources and more.

November Tale

An overbought pullback later this week looks likely, and it should lead to another rally – but we had the same set up in November and it didn’t pan out that way.

DaVita Inc. Schedules Capital Markets Day For September 10, 2019

DaVita Inc. Schedules Capital Markets Day For September 10, 2019

DENVER, Aug. 27, 2019 /PRNewswire/ -- DaVita Inc.

Davita Announces Final Results Of Self-Tender Offer

Davita Announces Final Results Of Self-Tender Offer

DENVER, Aug. 22, 2019 /PRNewswire/ --  DAVITA INC.

DaVita Announces Preliminary Results Of Self-Tender Offer

DaVita Announces Preliminary Results Of Self-Tender Offer

DENVER, Aug. 19, 2019 /PRNewswire/ --  DAVITA INC.

Notable Wednesday Option Activity: DVA, HIIQ, DNKN

Notable Wednesday Option Activity: DVA, HIIQ, DNKN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in DaVita Inc , where a total of 42,323 contracts have traded so far, representing approximately 4.2 million underlying shares. That amounts to about 127.3% of DVA's average daily trading volume over the past month of 3.3 million shares.

DaVita Announces New Senior Secured Credit Agreement

DaVita Announces New Senior Secured Credit Agreement

DENVER, Aug. 12, 2019 /PRNewswire/ -- DAVITA INC.

DaVita Inc. 2nd Quarter 2019 Results

DaVita Inc. 2nd Quarter 2019 Results

DENVER, Aug. 1, 2019 /PRNewswire/ -- DaVita Inc.

See How DaVita Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How DaVita Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that DaVita Inc is the #65 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

Innovation In Home Care Delivery Improves The Quality Of Life For More Kidney Patients

Innovation In Home Care Delivery Improves The Quality Of Life For More Kidney Patients

Company reports steady growth of home-based treatments

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DVA, HTZ, JAZZ, SKIS, SYKE Downgrades: SLAB, TZOO, VFC Initiations: OBNK, STXB Read on to get TheStreet Quant Ratings' detailed report:

DaVita Soars on Upbeat Earnings Guidance

DaVita Soars on Upbeat Earnings Guidance

The kidney dialysis services provider expects its second-quarter profit to be higher than expected.

DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share

DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share

DENVER, July 22, 2019 /PRNewswire/ -- DAVITA INC. (NYSE: DVA), "DaVita," a Fortune 500 ® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of kidney care services...

DaVita Inc. Announces Preliminary Second Quarter 2019 Results And Updated Guidance For Fiscal Year 2019

DaVita Inc. Announces Preliminary Second Quarter 2019 Results And Updated Guidance For Fiscal Year 2019

DENVER, July 22, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita" or "Company"), today announced preliminary second quarter 2019 financial and operating results and updated guidance for fiscal year 2019.

DaVita Inc. Schedules 2nd Quarter 2019 Investor Conference Call

DaVita Inc. Schedules 2nd Quarter 2019 Investor Conference Call

DENVER, July 22, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 9 countries around the world, announced today that it will hold its quarterly conference call to discuss second quarter...

DaVita Statement On Advancing American Kidney Health

DaVita Statement On Advancing American Kidney Health

DENVER, July 10, 2019 /PRNewswire/ --  DaVita Kidney Care appreciates President Trump, the Administration and Secretary Azar for taking steps to improve the lives of kidney patients.

DaVita Continues To Transform Patient Care, Pushes For Continued Innovation In Kidney Care

DaVita Continues To Transform Patient Care, Pushes For Continued Innovation In Kidney Care

Affirms commitment to value-based kidney care and improving kidney disease prevention, home dialysis and transplantation

Looking for Winners of a Potential Healthcare Policy Proposal

Two companies that could benefit are CVS Health and UnitedHealth Group.

DaVita Lower as HHS Plans to Emphasize At-Home Dialysis Treatment

DaVita Lower as HHS Plans to Emphasize At-Home Dialysis Treatment

A looming federal health-care shift has the potential to shake up the $24 billion dialysis industry, in which DaVita is a leading player.

Harvest One Completes Acquisition Of Delivra

Harvest One Completes Acquisition Of Delivra

TORONTO, July 3, 2019 /PRNewswire/ - Harvest One Cannabis Inc. (TSXV: HVT, OTCQX: HRVOF - " Harvest One") and Delivra Corp.

Harvest One And Delivra Provide Update On Closing Date Of Transaction

Harvest One And Delivra Provide Update On Closing Date Of Transaction

VANCOUVER, June 28, 2019 /PRNewswire/ - Harvest One Cannabis Inc. (" Harvest One") (TSXV: HVT; OTCQX: HRVOF) and Delivra Corp.

Optum Completes Acquisition Of DaVita Medical Group From DaVita

Optum Completes Acquisition Of DaVita Medical Group From DaVita

Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation's leading independent medical groups, from DaVita Inc.

Buffett's Berkshire Hathaway Closes Below $300,000

Buffett's Berkshire Hathaway Closes Below $300,000

Shares of Warren Buffett's investment vehicle, Berkshire Hathaway, ended the day below $300,000 for the first time since late March.

Buy-Write Magic With DaVita

Buy-Write Magic With DaVita

Buy-write combinations are a very powerful investment technique.

Rally or Selloff?: Cramer's 'Mad Money' Recap (Friday 5/17/19)

Rally or Selloff?: Cramer's 'Mad Money' Recap (Friday 5/17/19)

Jim Cramer says we'll need to pay close attention to retailers' earnings. Here's your game plan for next week.

Arena Pharmaceuticals, DaVita, Merck: 'Mad Money' Lightning Round

Arena Pharmaceuticals, DaVita, Merck: 'Mad Money' Lightning Round

Jim Cramer weighs in on Arena Pharmaceuticals, DaVita, Merck, Abbott Laboratories, IAC Interactive, Yext and more.

TheStreet Quant Rating: B- (Buy)